Close

bluebird bio (BLUE) to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual Congress

Go back to bluebird bio (BLUE) to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual Congress
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 0.95 --0 (-0%)
Previous Close $0.95    52 Week High $95.28 
Open $0.95    52 Week Low $35.37 
Day High $0.95    P/E N/A 
Day Low $0.95    EPS $-1.81 
Volume 300